METHODS FOR TREATMENT WITH BUCINDOLOL BASED ON GENETIC TARGETING

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150276717A1
SERIAL NO

14546900

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns the use of methods for evaluating bucindolol treatment for a patient, particularly one with heart failure. It concerns methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient is homozygous for the Arg 389 polymorphism in the β1-adrenergic receptor (AR).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE201 REGENT ADMINISTRATIVE CENTER BOULDER CO 80309

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BRISTOW, MICHAEL ENGLEWOOD, US 21 120
Liggett, Stephen B CLARKSVILLE, US 22 150

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation